About golimumab
Tumor necrosis factor (TNF) blocker
Used for
- Rheumatoid arthritis, usually with methotrexate
- Psoriatic arthritis
- Ankylosing spondylitis and non-radiographic axial spondyloarthritis
- Ulcerative colitis in adults
Usual adult dose
Usually injected under the skin once monthly. Ulcerative colitis dosing may start with larger doses, then continue monthly.
Usual dose in children
For juvenile psoriatic arthritis, usually injected once monthly; dose depends on body weight.
Common side effects
- Upper respiratory infections
- Injection-site reactions
- Headache
- Increased liver enzymes
Important warnings
- Increases risk of serious infections, including tuberculosis and fungal infections
- Screen for tuberculosis and hepatitis B before treatment
- Avoid live vaccines during treatment
- May increase risk of certain cancers and worsen heart failure
Pregnancy
Limited data; use only when benefits outweigh potential risks. Discuss treatment during pregnancy with a clinician.
Breastfeeding
Limited information; discuss potential benefits and risks with a clinician.
Interactions
- Other biologic medicines or TNF blockers increase infection risk
- Live vaccines may cause infection
- Avoid combining with abatacept or anakinra
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.